SEEKING BUYER
(Expired) High-Growth, Innovative Nutraceutical Opportunity
Healthcare · United States
revenue: $11,028,987
ebitda: $3,178,100
Exclusivity:
Exclusive Representation
SBA Eligiblity:
Not SBA Eligible
Revenue:
$11,028,987
EBITDA:
$3,178,100
Please send email to redacted if interested Established Pharmaceutical Company: Portfolio of 12 well-branded, highly-recognizable products for children, adults, and pets. Strong Financial Performance: Estimated to capture ~$10 million in annual revenue with an impressive 21% CAGR sinceredactedLogistical Efficiency: Identified strategic logistical improvements poised to double net income.